Détail de l'auteur
Auteur M. NORDENTOFT |
Documents disponibles écrits par cet auteur (3)
Ajouter le résultat à votre sélection Affiner la recherche
C. HJORTHOJ ; M. L. D. OSTERGAARD ; M. E. BENROS ; N. G. TOFTDAHL ; A. ERLANGSEN ; J. T. ANDERSEN ; M. NORDENTOFT | 2015
Dans Lancet Psychiatry (The) (Vol.2, n°9, September 2015) Article : PériodiqueBackground: People with severe mental illness have both increased mortality and are more likely to have a substance use disorder. We assessed the association between mortality and lifetime substance use disorder in patients with schizophrenia, b[...]C. HJORTHOJ ; W. COMPTON ; M. STARZER ; D. NORDHOLM ; E. EINSTEIN ; A. ERLANGSEN ; M. NORDENTOFT ; N. D. VOLKOW ; B. HAN | 2023
Dans Psychological Medicine (Vol.53, n°15, November 2023) Article : PériodiqueBackground: Previous research suggests an increase in schizophrenia population attributable risk fraction (PARF) for cannabis use disorder (CUD). However, sex and age variations in CUD and schizophrenia suggest the importance of examining differ[...]O. H. JEFSEN ; A. ERLANGSEN ; M. NORDENTOFT ; C. HJORTHOJ | 2023
Dans JAMA Psychiatry (Vol.80, n°8, August 2023) Article : PériodiqueKey Points: Question: Is cannabis use disorder associated with an increased risk of psychotic and nonpsychotic unipolar depression and bipolar disorder? Findings: In this cohort study of 6 651 765 individuals in Demark, cannabis use disorder w[...]